News

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
The drug gained a following in some circles for its supposed ability to treat COVID-19 safely, something all major medical ...
KalVista Pharmaceuticals shares jumped in premarket trading Monday after the company said it has received regulatory approval for its treatment of hereditary angioedema. Shares traded 20% higher ahead ...
Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...
NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...
A massive analysis recently published in the journal Aging Cell revealed that rapamycin — the immunosuppressant drug turned ...
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for ...
These recent food recalls involve cream cheese, eggs, shrimp, and ice cream due to serious health risks including salmonella ...
Americans are increasingly demanding that chemicals and toxic food dyes be removed from items they consume, clean with, wear, ...
Smucker's commits to remove artificial dyes from sugar-free fruit spreads, ice cream toppings and other products by 2027, ...